International Clinical Trial: Construction of a Machine Learning-Based Predictive Model for Treatment Failure in Elderly Acute Myeloid Leukemia (AML) Using the Venetoclax and Azacitidine (VA) Regimen

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115834) titled 'Construction of a Machine Learning-Based Predictive Model for Treatment Failure in Elderly Acute Myeloid Leukemia (AML) Using the Venetoclax and Azacitidine (VA) Regimen' on Dec. 31, 2025.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Second Affiliated Hospital of Army Medical University

Condition: acute myeloid leukaemia

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Observation group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=295684

Published by HT D...